[See 2019 update] In conjunction, we are working on a cure for chronic hepatitis, with promising results on three compounds in early clinical development. Hepatitis B is a liver infection caused by the hepatitis B virus. The achievement of hepatitis B surface antigen (HBsAg) loss and its durability off treatment are of paramount importance for current and future anti‐hepatitis B virus (HBV) strategies. 1 in this issue of Hepatology Communications . Scientists from Karolinska Institutet and Hannover Medical School have published two studies that provide insights into how the immune system responds and helps to clear a hepatitis B infection after treatment interruption. Study participant were predominantly male (93%), just over half were non-Hispanic Black (51%), all except one were on antiretroviral therapy and all but three were taking treatment for hepatitis B, either as part of antiretroviral therapy (tenofovir, emtricitabine or lamivudine, 80%) or the anti-hepatitis B drug entecavir (15%). Australian hepatitis organisations have expressed concern that 2019 funding for hepatitis commitments in 2019 Health Budgets are yet to be released even as new funding was announced for the 2020 budget. Nov. 18, 2020, 10:00 AM. Hepatitis B Foundation co-founders chosen for major new award from the American Association for the Study of Liver Diseases Hepatitis B Foundation announces recipient of 2021 Blumberg Prize Hepatitis B Foundation applauds HHS letter on discrimination against people living with hepatitis B who are pursuing careers in health care. Despite this, research into HBV is drastically underfunded, to the point that it was recently compared to a neglected tropical disease. First-in-class hepatitis B/D drug raises cure hope Those taking the regimen saw virus levels decline . Shown here are: Sreya Biswas, Ph.D. (left), Benjamin Burwitz, Ph.D. (center), and Lauren Rust, Ph.D. (right) . Ideally, a hepatitis B cure would also reduce a person’s risk of liver failure and liver cancer. In contrast, the older interferon treatments last between 6 months and 12 months. Latest News; World Hepatitis Day. Latest News. WHA statement: scientists who discovered hepatitis C virus awarded Nobel Prize. 23 Nov 2020 Tina Kasap. Vacancy: Events Manager . Everyone living with chronic hepatitis B should be receiving ongoing care. VACANCY: FUNDRAISING AND BUSINESS DEVELOPMENT MANAGER. News from the World Hepatitis Alliance. "The only thing [hepatitis B and COVID-19] have in common is that they are both caused by viruses. June 9, 2020 — Researchers have identified and described a new and unique subset of human cells that are involved in the immune response against hepatitis B … 22 Oct 2020 Chris Wingrove. Treatment to prevent hepatitis B infection after exposure If you know you've been exposed to the hepatitis B virus and aren't sure if you've been vaccinated, call your doctor immediately. TherVacB – A THERAPEUTIC VACCINE TO CURE HEPATITIS B European Commission and TherVacB join forces. You are here. Campaign Materials; Search form. News Release 17-Nov-2020 'Meet people where they are:' local health departments key to hepatitis B vaccination West Virginia University. News; Stories; Hepatitis B cure sought with help of animal research Browse Stories ... 2020 Portland, Oregon ... primate model of hepatitis B and is working with companies that are interested in using the model to evaluate potential new treatments for chronic hepatitis B. by Ed Susman, Contributing Writer, MedPage Today April 10, 2019 While it's too soon … Hepatitis B is one type of hepatitis – a liver disease- caused by the hepatitis B virus (HBV). (b) The Prospectus stipulates that approximately 10.0% of the Net Proceeds is originally intended to be used for the Group's research and development of … Nominate your regional board member . An injection of immunoglobulin (an antibody) given within 12 hours of exposure to the virus may help protect you from getting sick with hepatitis B. Latest News . German biotech Myr Pharma has reported positive phase 2b trial data with bulevirtide in patients with chronic hepatitis B and D, driving the virus down to undetectable levels in some patients. Search . Because HBsAg loss is a rare event, multicenter studies and pooled analyses may be instrumental, as demonstrated by Lok et al. Unlocking the door to hepatitis B cure. A discovery by Florida State University College of Medicine researchers is expected to open the door for new and more potent treatment options for many of … 9 Nov 2020 … 9 Nov 2020 Chris Wingrove. New strategy to cure chronic hepatitis B infection. Home » Resources. June 2018 – Hepatitis B virus (HBV) takes a huge human and economic toll. Already, preventive vaccines have reduced the rate of hepatitis B infection among children, and antivirals have, for some, reduced the risk of the infection leading to liver cancer. Also on the medical innovation front: a new wave of technological advances in development that are poised to help the World Health Organization eliminate viral hepatitis as a public health threat by 2030. Read the latest on prevention of hepatitis B virus with the hepatitis B vaccine. Assembly Bio's hepatitis B program flops as a potential cure in PhII, sending shares spiraling . Overall, new drugs cure the hepatitis C infection in 90 to 100 percent of people, according to the FDA. developed a new treatment for chronic hepatitis B infections that was 100 per cent successful in preclinical trials. Scientists at the Doherty Institute, have recently made two key discoveries that will contribute to global efforts to develop a therapeutic cure for hepatitis B (HBV). The virus is passed from person to person through bodily fluids, including blood or semen. Hepatitis B: New therapeutic approach. Max Gelman Associate Editor. Aiming for a cure Spread by contact with infected blood and other body fluids, hepatitis B (HBV) can be associated with irreversible liver damage, chronic active hepatitis, and the development of cirrhosis and hepatocellular carcinoma. The hepatitis B virus chronically infects around 260 million humans, more than three percent of the world’s population. Search . Hepatitis B spreads by contact with an infected person's blood, semen or other body fluid. Aarhus University. Hepatitis B : Review in-depth clinical information, latest medical news, and guidelines on hepatitis B infection. 5 Oct 2020 … Medicines for the treatment of hepatitis C are available under the Pharmaceutical Benefits Scheme (PBS) and have a cure rate of greater than 90 per cent.. More information. As would be expected, given Vir’s coronavirus work, yesterday’s announcement of the first results of a trial of VIR-2218 elicited no market reaction. (2019, December 5). Nominate your regional board member . PRESS RELEASE PR Newswire . Latest news. Anti-hepatitis medicine surprises: New effective treatment of hep C not only combats the virus, but is also effective against complications. Research News. Australian scientists have found a potential cure for hepatitis B virus (HBV) infections, with a promising new treatment proving 100 per cent successful in eliminating the infection in preclinical models. VACANCY: FUNDRAISING AND BUSINESS DEVELOPMENT MANAGER. But yesterday the company launched a bid to join Arrowhead and Dicerna in the race to develop a functional cure for this viral disease. Overview. GUILD 2020 HBV: Rethink the Free Pass for Immune-Tolerant Patients There might well be a cure for hepatitis B in coming years, just like there is now for hepatitis C, an expert reports. Change in Use of Proceeds From the Global Offering for Expansion of R&D Portfolio into Hepatitis B Clinical Cure and NASH . The new NIH plan defines a hepatitis B “cure” as a sustained loss of a specific protein on the surface of HBV called hepatitis B virus surface antigen — preferably with antibodies against the antigen and undetectable viral DNA after completion of a finite course of treatment. Test all patients for evidence of current or prior hepatitis B virus (HBV) infection before initiating treatment with EPCLUSA. Researchers at Technical University of Munich (TUM), Helmholtz Zentrum München and the German Center for Infection Research (DZIF) have developed a novel therapeutic approach to cure chronic hepatitis B. 01 Sep 2020. The cure for hepatitis C, developed in the last decade, sparked renewed hope that the milestone can be duplicated in hepatitis B. On 1 March 2016 four direct acting antiviral medicines for the treatment of hepatitis C were listed on the Pharmaceutical Benefits Scheme (PBS). Share. Latest News; World Hepatitis Day. There are a number of drugs used to treat hepatitis B which are available via prescription from a hospital pharmacy or your local chemist. The role of viral hepatitis as a public health threat has long been underestimated. Print E … These new and effective medicines have a cure rate of greater than 90 per cent. Meeting Coverage > EASL Cure for Hepatitis B Pushed — Disease affecting 257 million people needs better treatment. November 6, 2020 07:09 AM EST. But hope for a cure is growing. For the latest news on the COVID-19 pandemic follow our live updates. R&D. New medicines for hepatitis C treatment. Campaign Materials; Search form. More information: Core components of DNA lagging strand synthesis machinery are essential for hepatitis B virus cccDNA formation, Nature Microbiology (2020). HBV reactivation has been reported in HCV/HBV coinfected patients who were undergoing or had completed treatment with HCV direct acting antivirals (DAAs) and were not receiving HBV antiviral therapy. 23 Nov 2020 Tina Kasap.